Edition:
United Kingdom

People: Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

5.00USD
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
$5.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,604
52-wk High
$7.99
52-wk Low
$3.46

Rickey, Paul 

Mr. Paul Rickey, CPA. serves as Chief Financial Officer, Senior Vice President of the company. He has served as our senior vice president and chief financial officer since the completion of the Merger in July 2017 and previously served as Private Alpine’s senior vice president and chief financial officer since April 2017. Mr. Rickey is an experienced executive who has spent over 16 years guiding financial strategy in the life sciences and technology industries. Prior to his joining Private Alpine in 2017, Mr. Rickey served as chief financial officer of Sound Pharmaceuticals, overseeing finance, accounting and human resources. Before joining Sound Pharmaceuticals in 2016, Mr. Rickey was vice president of finance and administration of Immune Design Corp., (Nasdaq:IMDZ) a publicly traded biotechnology company, where he helped complete the company’s private offerings, initial public offering, and follow-on financing, and also oversaw the corporate development, accounting and human resource functions. Before joining Immune Design in 2009, Mr. Rickey was corporate controller of Northstar Neuroscience, a publicly-traded medical device company, where he managed the company’s finance and accounting groups following Northstar’s initial public offering. Prior to his role at Northstar Neuroscience, Mr. Rickey was the accounting manager for Mobliss, Inc., a mobile technology company that was sold to Index Corp., of Japan. Mr. Rickey started his finance career at Ernst & Young LLP. Mr. Rickey graduated from the University of Washington with a B.A. and Masters in Professional Accounting and is a certified public accountant.

Basic Compensation

Total Annual Compensation, USD 256,250
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 245,410
Fiscal Year Total, USD 501,660

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --